VECOXAN 2.5 MG/ML ORAL SUSPENSION FOR LAMBS AND CALVES

Ország: Írország

Nyelv: angol

Forrás: HPRA (Health Products Regulatory Authority)

Aktív összetevők:

DICLAZURIL

Beszerezhető a:

Elanco Animal Health, Eli Lilly and Company Limited

ATC-kód:

QP51AJ03

INN (nemzetközi neve):

DICLAZURIL

Adagolás:

2.5 Mg/Ml

Gyógyszerészeti forma:

Oral Suspension

Recept típusa:

LM: Licensed Merchant as defined in relevant national legislation

Terápiás csoport:

Cattle, Sheep

Terápiás terület:

diclazuril

Terápiás javallatok:

Coccidiostats

Engedélyezési státusz:

Authorised

Engedély dátuma:

2012-04-20

Termékjellemzők

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Vecoxan 2.5 mg/ml Oral Suspension for lambs and calves
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
White, oral suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Ovine (lambs) and bovine (calves).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In lambs:
Prevention of coccidiosis caused by_ Eimeria crandallis_ and_ Eimeria
ovinoidalis_.
In calves:
Prevention of coccidiosis caused by_ Eimeria bovis_ and_ Eimeria
zuernii_.
If there is no recent and confirmed history of clinical coccidiosis,
the presence of coccidia in the flock or herd should be
confirmed by faecal sampling prior to treatment.
4.3 CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance or to
any of the excipients.
Each ml contains:
ACTIVE SUBSTANCE:
Diclazuril
2.5 mg
EXCIPIENTS:
Methyl parahydroxybenzoate (E218) 1.8 mg
Propyl parahydroxybenzoate
0.2 mg
For a full list of excipients see 6.1
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_4_
_/_
_1_
_1_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_4_
_4_
_3_
_2_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Avoid underdosing which may be due to underestimation of body weight,
misadministration of the product or lack of
calibration of the dosing device (if any).
Calves: in certain cases, only a transient reduction of oocyst
shedding may be achiened.
Suspected clinical cases